Emory & Henry College (E&H or Emory) is a private liberal arts college in Emory, Virginia. The campus comprises 335 acres (1.36 km2) of Washington County, which is part of the Appalachian highlands of Southwest Virginia. Founded in 1836, Emory & Henry College is the oldest institution of higher learning in Southwest Virginia.
The authors have withdrawn this manuscript because of statistical software coding errors discovered after submission in the approach used to aggregate overdose deaths. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.
Background: Transcriptomic gene signatures are widely used to infer pathway activity and biological mechanism from bulk cancer expression data, yet current evaluation strategies primarily emphasize internal coherence, predictive performance, or scoring robustness. A quantitative framework for assessing how much signature variation remains independent of background expression structure has been lacking. Results: Unlike existing single-number signature-quality metrics such as Berglund uniqueness, residual-ratio auditing reports a trajectory across null-model richness: for each signature we compute the residual ratio resratio(k) = 1 - sum_{j=1}^{k}(mathbf{q}_j^top mathbf{h})^2 at progressively enriched expression-PC subspaces, together with an inverse-participation-ratio (IPR) concentration diagnostic that reports the effective number of axes absorbing each signature. Applied to a curated 17-entry benchmark, all 50 MSigDB Hallmark gene sets, and 1181 Reactome pathways across 8 TCGA cancer types (4462 samples), with external validation in METABRIC, the framework produces two complementary readouts. First, the curated panel is absorbed into the ExprPC50 subspace at residual ratios 18--43% below size-matched random 30-gene baselines in every cancer (curated mean resratio range 0.109--0.177 vs. random mean 0.18--0.288), providing the framework's central quantitative discrimination between biologically coherent signatures and arbitrary gene combinations. Second, within the curated panel the ExprPC50 residual ratio is negatively correlated with the top-5 absorption concentration in every cancer (Spearman rho from -0.59 in PRAD to -0.89 in SKCM, median -0.71; all 8 significant at p < 0.05, most at p < 10^-3); we report this correlation as a descriptive geometric property of the null-model coordinate system rather than as a biological law, because 1000 random 30-gene draws projected through the same top-50 expression-PC basis reproduce the same pan-cancer median rho (-0.73; Supplementary Table~ref{tab:S17}), and it is robust to compositional nuisance: after rebuilding the null basis as immune-PC1 oplus stromal-PC1 oplus proliferation-PC1 plus 47 residual PCs, the per-cancer rho becomes more negative rather than shallower (median -0.86; Supplementary Table~ref{tab:S18}), ruling out tumor purity, immune infiltrate, and stromal fraction as drivers of the pattern. Because absorption at ExprPC50 is a geometric property of how any signature direction sits in expression-PC space, tier-level distributional structure at this operating point is not separable beyond the low-vs-upper band split: a Kruskal--Wallis omnibus is significant (p = 4.9 x 10^-13), but pairwise Dunn's post-hoc tests show that Tiers~1, 4, and~5 are not separable (p_{\mathrm{BH}} > 0.2). The trajectory shape itself is empirically bootstrap-invariant: across 200 sample-level fixed-basis bootstrap resamples of the 17 curated entries in BRCA, the mean pairwise Pearson correlation of trajectory-shape vectors is 0.999, and individual cell-level 95% bootstrap CI half-widths at B = 1000 resamples are in the range 0.002--0.053. External replication in the METABRIC breast cancer cohort (n_{\text{samples}} = 1980, microarray) showed moderate-to-strong rank-ordering concordance with TCGA-BRCA across the 17 curated entries (Spearman rho = 0.72 on the 17-signature ordering, 95% Fisher-z CI 0.37--0.89, p = 0.001). Under an upper-bound sensitivity analysis, 45 of 50 Hallmark gene sets and 992 of 1181 Reactome pathways had ExprPC200 residual ratios below the mean of their size-matched random baselines---a descriptive statistic reflecting axis alignment under rich null models, not a failure rate. In causal DAG simulations (n_{mathrm{rep}} = 100 replicates), a signature driven entirely by a latent confounder retained resratio = 0.233 at ExprPC50, numerically comparable to Tier~1 validated drivers, so a single-point residual ratio cannot adjudicate confounder-independence. The framework's load-bearing signals are therefore the trajectory shape (statistically invariant under sample-level resampling) and the magnitude gap between the curated panel and its random 30-gene baseline (the curated-vs-random discrimination), read jointly---not the value of resratio at any single null-model dimensionality. Conclusions: Residual-ratio auditing provides an interpretable and practical framework for quantifying how much of a transcriptomic gene signature's variance remains orthogonal to a chosen background-expression model. The two statistically reliable quantities it reports are (i) the shape of the trajectory resratio(k) across null-model richness, which is bootstrap-invariant across sample-level resamples, and (ii) the magnitude gap between the curated panel's residual ratio and size-matched random 30-gene baselines at a fixed operating point, which is 18-43% in all 8 TCGA cancers and survives a purity-aware null-model construction. The negative correlation between resratio and the top-5 absorption concentration $c$ (curated-panel median rho = -0.71) is reproduced by random 30-gene sets under the same basis (random-draw median rho = -0.73) and is therefore best read as a descriptive geometric property of the null-model coordinate system rather than a biological discovery about curated signatures. Any single operating-point residual ratio carries materially wider cell-level uncertainty than the trajectory shape and cannot, on its own, adjudicate confounder-independence. The framework's outputs describe a signature's geometric relationship to modeled background expression structure and do not evaluate clinical utility: a signature with a low residual ratio may still be clinically valuable when that low value reflects alignment with a strong prognostic or actionable program such as proliferation, immune infiltration, or cell cycle, and the framework is not a substitute for calibrated prognostic or predictive classifiers. All findings are based on bulk RNA-seq (TCGA PanCancer Atlas, 8~cancer types) and microarray (METABRIC) data; transfer to single-cell, single-nucleus, or spatial transcriptomics is out of scope and not claimed. Used within this scope---reading the trajectory shape and the magnitude-gap signal jointly, rather than the value of resratio at any one k---the framework adds a complementary audit layer to existing pathway-scoring and experimental-validation workflows, and supports more calibrated interpretation, comparison, and reporting of transcriptomic gene signatures in cancer studies.
Tobacco smoking, a major cause of preventable mortality, upregulates β2 subunit-containing nicotinic acetylcholine receptors (β2*-nAChR) in most brain regions. Although the α4 subunit most frequently co-assembles with β2, other subunits likely assemble with β2 and contribute to distinct aspects of nicotine-mediated behaviors, but these factors are poorly understood in people. This work performed independent component analysis (ICA) of [18F]Flubatine positron emission tomography (PET) image data to identify maximally independent sources of specific binding to β2*-nAChRs. We then compared their magnitudes (loading coefficients) in people who recently stopped smoking cigarettes (abstinent smokers; n = 26) and people who never smoked cigarettes (non-smokers; n = 20). ICA identified 3 reproducible components: IC1 (36% of variance) in medial thalamus, lateral thalamus, and red nucleus; IC2 (18% of variance) in ventral thalamus, lateral geniculate, and midbrain; IC3 (19% of variance) in cerebellum and optic circuitry in midbrain. Nicotine challenge in an independent sample (n = 9) reduced loading coefficients of all components, confirming specific binding to nAChRs. Post-mortem autoradiography of cerebellum showed greatest [18F]Flubatine displacement by α3/α6β2*-nAChR blocker (α-Conotoxin MII) but low displacement by α6β2*-nAChR blocker (α-Conotoxin PIA), suggesting that IC3 measures α3β2*-nAChRs specific binding – a novel finding in living people. Loading coefficients of IC1 and IC2 were significantly lower in abstinent smokers compared to non-smokers. IC3 loading coefficients were significantly higher during extended smoking abstinence, and exploratory analyses suggested initial evidence for daily smoking amount correlating with nicotine dependence severity. These results could inform novel treatment development to help people quit smoking.
Schizophrenia is one of the most complex brain disorders, arising from multidimensional pathophysiological processes that span genetic vulnerability, neurotransmitter dysregulation, structural brain damage, and large-scale brain network dysfunction. Large-scale neuroimaging studies have consistently demonstrated the critical role of frontal brain regions in schizophrenia. Despite substantial progress, the precise localization of structural damage within these regions and the neurobiological mechanisms linking such alterations to disease pathology remain poorly understood. In this study, we included a total of 115 subjects from two sites of the B-SNIP dataset, comprising 60 healthy controls and 55 individuals with schizophrenia. We employed diffusion tensor imaging (DTI) to precisely characterize specific structural alterations in the frontal brain regions associated with schizophrenia. Our findings reveal significant microstructural abnormalities in the forceps minor, a major commissural white-matter tract that serves as a critical interhemispheric bridge between the bilateral frontal lobes. Network-level mapping further demonstrates that the forceps minor is closely integrated with large-scale brain networks, particularly the default mode network, and maintains strong structural connectivity with orbitofrontal regions-both of which are known to exhibit dysfunction in schizophrenia. Moreover, converging evidence suggests that the forceps minor plays an important role in the regulation of social behavior, a core domain of impairment in schizophrenia. Collectively, these findings identify the forceps minor as a promising structural imaging biomarker for schizophrenia and provide novel insights into the microstructural mechanisms underlying the disorder.